PRESS RELEASE published on 08/18/2023 at 14:50, 2 years 9 months ago Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
PRESS RELEASE published on 06/09/2023 at 09:05, 2 years 11 months ago MindBio Therapeutics Co-Founders Appear in Leading Australian Financial News Publication Ahead of Medicinal Psychedelics Legalisation in Australia
PRESS RELEASE published on 06/07/2023 at 03:10, 2 years 11 months ago MindBio Therapeutics CEO To Present at Emerging Equities Life Sciences VIP Event and Showcase MindBio's Research at Upcoming MAPS Psychedelics Science Conference in Colorado
Published on 05/28/2026 at 01:15, 6 hours 37 minutes ago JM Capital II Corp. Announces Departure of President, Chief Financial Officer and Chief Financial Officer Jay Freeman
Published on 05/28/2026 at 00:55, 6 hours 57 minutes ago First Helium Closes Oversubscribed $2.6 Million Placement
Published on 05/27/2026 at 23:42, 8 hours 10 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/27/2026 at 23:05, 8 hours 47 minutes ago Vox Royalty Announces Annual and Special Meeting Results
Published on 05/27/2026 at 23:05, 8 hours 47 minutes ago Avino Reports Voting Results of Its 2026 Annual General Meeting
Published on 05/28/2026 at 07:30, 22 minutes ago EVN AG: Business development in the first half of 2025/26
Published on 05/28/2026 at 07:30, 22 minutes ago Ernst Russ AG Publishes Business Figures for the First Quarter of 2026
Published on 05/28/2026 at 07:30, 22 minutes ago Northern Data Group Announces CFO Move to Advisory Role
Published on 05/28/2026 at 07:30, 22 minutes ago Magirus starts 2026 with strong momentum in Q1, record high order intake; Mutares initiates preparation of exit process
Published on 05/28/2026 at 07:30, 22 minutes ago BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
Published on 05/27/2026 at 23:00, 8 hours 52 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 11 hours 24 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 14 hours 7 minutes ago Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 14 hours 7 minutes ago Description of Share buyback program - May 2026
Published on 05/27/2026 at 17:45, 14 hours 7 minutes ago Report on share repurchases from 20 to 26 May 2026
